We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

8334:TSEGunma Bank, Ltd. Analysis

Data as of 2026-06-18 - not real-time

¥2,312.50

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Technical indicators are broadly supportive: the price sits comfortably above short‑ and long‑term moving averages, the MACD line sits above its signal, and momentum sits in a neutral‑to‑positive zone. Support appears solid near the lower band of recent range, while resistance lies just above the current level, suggesting upside potential if buying pressure holds. The market sentiment indicator signals extreme greed, and the low beta points to limited price swings relative to the broader market, though volatility remains elevated for a regional bank. Fundamentals present a mixed picture: valuation multiples are modest relative to peers, and operating margins are respectable, but cash flow generation is weak and the company does not pay a dividend. Revenue growth has been strong, yet the lack of free cash flow and a zero dividend payout raise questions about sustainability. Overall, the stock appears fairly valued with a modest upside horizon and limited downside given strong support levels and a defensive sector profile.
The recommendation leans toward a cautious accumulation stance: short‑term investors may hold or add on dips, medium‑term participants can consider buying on confirmation of continued price strength, and long‑term holders should monitor cash flow trends and any shifts in dividend policy. The bank’s solid capital ratios and stable market position offset cash flow concerns, but investors should stay alert to potential regulatory or macro‑economic headwinds that could affect profitability.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price above key moving averages
  • support level near current price
  • stable trading volume

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • bullish MACD crossover
  • valuation modest versus peers
  • solid capital base

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • absence of dividend reduces yield appeal
  • cash flow weakness
  • low beta and defensive sector positioning

Key Metrics & Analysis

Financial Health

Revenue Growth52.50%
Profit Margin30.03%
P/E Ratio14.9
ROE9.96%
ROA0.55%
P/B Ratio1.4
Op. Cash Flow¥-281375997952
Industry P/E17.1

Technical Analysis

TrendBullish
RSI54.9
Support¥2,094.00
Resistance¥2,425.00
MA 20¥2,278.88
MA 50¥2,232.72
MA 200¥1,910.57
MACDBullish
VolumeStable
Fear & Greed Index88.5

Valuation

Target Price¥2,450.00
Upside/Downside5.95%
GradeFair
TypeValue

Risk Assessment

Beta0.50
Volatility28.71%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.